lung adenocarcinoma Clinical Research Trials

Found 3 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 1
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Endocrinology
Recruiting

Rigosertib Plus Nivolumab for KRAS+ NSCLC Patients Who Progressed on First-Line Treatment

A Phase1/2a Study of Rigosertib plus Nivolumab in Stage IV Lung Adenocarcinoma Patients with KRAS Mutation who Progressed on First-Line Treatment

oophorectomy

platinum doublet

metastatic lung adenocarcinoma

rigosertib

bilateral oophorectomy

0 views
19 Feb, 2024

For Seniors
For adults
Recruiting in 1000s
Observational Study
all
Recruiting

Optimal EGFR TKIs Treatment Strategies for Lung Adenocarcinoma Harboring EGFR Exon 19 Deletion Variants

To determine the optimal EGFR TKIs treatment strategies for lung adenocarcinoma harboring EGFR exon 19 deletion variants

0 views
19 Feb, 2024

For pediatric ages
For Seniors
Recruiting in 100s
Observational Study
all
Family Medicine
Recruiting

A Prospective Cohort of Pulmonary Ground Glass Nodules Patients With Family History.

The aim of the present prospective cohort study (GGN-F) is to study the family aggregation of pulmonary ground glass nodules via the questionnaire survey and to investigate the underlying genetic mechanism via the biobank.

lung cancer

cancer

0 views
19 Feb, 2024

Filter By

Found 3 clinical trials

Rigosertib Plus Nivolumab for KRAS+ NSCLC Patients Who Progressed on First-Line Treatment

Optimal EGFR TKIs Treatment Strategies for Lung Adenocarcinoma Harboring EGFR Exon 19 Deletion Variants

A Prospective Cohort of Pulmonary Ground Glass Nodules Patients With Family History.